The European Federation of Pharmaceutical Industries and Associations (EFPIA) today published its “ The Pharmaceutical Industry in Figures” report, which reveals that the pharmaceutical industry is the most R&D intensive industrial sector in Europe and in 2020, it invested an estimated 39 billion euros ($55 billion) in R&D in Europe.
The cost of researching and developing a new chemical or biological entity was estimated at 1,926 million euros ($2,558 million in year 2013 dollars) in 2014 (DiMasi et al, Journal of Health Economics, January 2016).
The world pharmaceutical market was worth an estimated 943,667 million euros at ex-factory prices in 2020. The North American market (USA & Canada) remained the world’s largest market with a 49.0% share, well ahead of Europe, China and Japan.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze